Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Apex Biotechnology Corp: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

19 Apr 2014 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - APEX BIOTECHNOLOGY CORPORATION (1733-TW)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

24 Apr 2014 Thomson Reuters Stock Report 11 $25.00

Wright Investors Service Comprehensive Report for Apex Biotechnology Corporation

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

13 Apr 2014 Wright Reports 42 $75.00

Apex Biotechnology Corp. (1733) - Financial and Strategic SWOT Analysis Review

Apex Biotechnology Corp. (1733) - Financial and Strategic SWOT Analysis Review Summary Apex Biotechnology Corp. (ApexBio) is ...

10 Apr 2014 GlobalData 30 $125.00

五鼎(1733.TT)靜待產業秩序回穩與新產品效應發酵,維持中立

靜待產業秩序回穩與新產品效應發酵,維持中立:預估五鼎2014年營收20.8億元(+13.5%YoY),毛利率31.3%,稅後淨利3.77億元(+0.9%YoY),稅後EPS 3.82元。投資建議方面,考量營收佔比約七成之美國市場在醫改政策降低補貼,產...

07 Mar 2014 SinoPac Sec Investment Service Traditional Chinese 4 $23.00

Apex Biotechnology Corp. (1733) - Financial and Strategic SWOT Analysis Review

Apex Biotechnology Corp. (1733) - Financial and Strategic SWOT Analysis Review Summary Apex Biotechnology Corp. (ApexBio) is ...

10 Jan 2014 GlobalData 30 $125.00

Apex Biotechnology Corp. (1733) - Financial and Strategic SWOT Analysis Review

Apex Biotechnology Corp. (1733) - Financial and Strategic SWOT Analysis Review Summary Apex Biotechnology Corp. (ApexBio) is ...

26 Dec 2013 GlobalData 31 $125.00

五鼎生物技術 (1733 TT, NT$70.7, 持有): 評等由「增加持股」調降為「持有」

醫改烏雲罩頂 獲利曙光未現 因美國醫改政策正式實施日期延後,公司短期營運受負面影響,其中3Q13獲利季減達68.3%,4Q13獲利更將持續下探;預期最快明年2月美國預算案取得共識後方見轉機 新產品推廣一如規劃進行,對公司後續營運表現仍存期待,...

20 Nov 2013 KGI Greater China 7 $58.00

Apex Biotechnology (1733 TT, NT$70.7, N): Downgrade to Neutral

Obamacare delayed; earnings way off Obamacare delay detrimental near term; earnings fell 68.3% QoQ in 3Q13, set to fall fu...

20 Nov 2013 KGI Greater China 7 $69.00

Apex Biotechnology Corp. (1733) - Financial and Strategic SWOT Analysis Review

Apex Biotechnology Corp. (1733) - Financial and Strategic SWOT Analysis Review Summary Apex Biotechnology Corp. (ApexBio) is ...

08 Oct 2013 GlobalData 31 $125.00